←Back to Expert Scholars
Translational Medicine / 转化医学KRAS Combination Therapy
Piro Lito
MD, PhD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Associate Member
50
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Piro Lito is a leader in KRAS G12C inhibitor biology and resistance. His laboratory has defined feedback reactivation mechanisms that motivate rational combination strategies with SHP2, MEK, and EGFR inhibitors. His work directly informs combination trial designs for KRAS mutant lung and colorectal cancers.
Share:
🧪Research Fields 研究领域
KRAS
targeted therapy
resistance mechanisms
combination therapy
lung cancer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Piro Lito 的研究动态
Follow Piro Lito's research updates
留下邮箱，当我们发布与 Piro Lito（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment